前列腺癌主动监测最佳实践:英国前列腺癌协会共识声明
该共识声明基于系统文献检索、英国泌尿外科部门信息自由请求数据及患者调查访谈,由英国前列腺癌协会主动监测专家参考组制定。声明指出各国及国内主动监测在风险分层、纳入标准和随访方案上差异显著,患者需要更多信息、心理支持及指定医疗专业人员。专家组就纳入/排除标准、随访方案和停止主动监测时机达成30条共识声明。
要点
- 主动监测实践在英国及国际间存在显著差异。
- 患者需要更多信息、心理支持和指定医疗专业人员。
- 专家组达成30条关于主动监测最佳实践的共识声明。
核心结论
- 英国及国际主动监测实践存在显著差异。
- 患者对治疗决策参与度和专业支持有明确观点。
- 专家组制定了主动监测最佳实践共识声明。
研究设计与样本
- 基于系统文献检索、信息自由请求数据和患者调查访谈制定共识声明。
- 由英国前列腺癌协会主动监测专家参考组讨论完善。
主要发现
- 指南和方案在风险分层、主动监测纳入标准和方案上差异显著。
- 患者和医疗专业人员识别了主动监测有效性的临床、情感和流程需求。
- 患者在讨论主动监测时及前2年需要更多信息和心理支持。
- 患者希望有指定医疗专业人员讨论问题或担忧。
关键数值与推荐
- 专家组达成30条共识声明,分组为纳入/排除标准、随访方案和停止主动监测时机。
临床怎么用
- 临床可参考共识声明优化主动监测的纳入、随访和停止时机。
- 应重视患者信息需求和心理支持,提供指定医疗专业人员。
局限性
- 主动监测最佳实践及多参数磁共振成像应用的证据仍在发展中。
- 需要进一步研究确定如何优化主动监测结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop a consensus statement on current best practice of active surveillance (AS) in the UK, informed by patients and clinical experts. SUBJECTS AND METHODS: A consensus statement was drafted on the basis of three sources of data: systematic literature search of national and international guidelines; data arising from a Freedom of Information Act request to UK urology departments regarding their current practice of AS; and survey and interview responses from men with localized prostate cancer regarding their experiences and views of AS. The Prostate Cancer UK Expert Reference Group (ERG) on AS was then convened to discuss and refine the statement. RESULTS: Guidelines and protocols for AS varied significantly in terms of risk stratification, criteria for offering AS, and protocols for AS between and within countries. Patients and healthcare professionals identified clinical, emotional and process needs for AS to be effective. Men with prostate cancer wanted more information and psychological support at the time of discussing AS with the treating team and in the first 2 years of AS, and a named healthcare professional to discuss any questions or concerns they had. The ERG agreed 30 consensus statements regarding best practice for AS. Statements were grouped under headings: 'Inclusion/Exclusion Criteria'; 'AS follow-up protocol' and 'When to stop AS'. CONCLUSION: Significant variation currently exists in the practice of AS in the UK and internationally. Men have clear views on the level of involvement in treatment decisions and support from their treating professionals when receiving AS. The Prostate Cancer UK AS ERG has developed a set of consensus statements for best practice in AS. Evidence for best practice in AS, and the use of multiparametric magnetic resonance imaging in AS, is still evolving, and further studies are needed to determine how to optimize AS outcomes.
引用
- Merriel SWD, Hetherington L, Seggie A, et al. Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement. BJU Int. 2019. PMID: 30742733. doi:10.1111/bju.14707
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。